Cilostazol promotes vascular smooth muscle cell differentiation via the cAMP/PKA/CREB pathway, providing a mechanistic basis for its role in reducing neointimal formation.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating in animal models; leaves open clinical translation to human neointimal prevention.
Chen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: